Evolus (EOLS) Live Share Price, Invest From India

Evolus Stock Performance

as on September 4, 2026 at 2:15 pm IST

Day's Low
Day's High
$8.91
Day's Price Range
$9.08
$9.05
1.55%
Downside
0.33%
Upside
52 Week's Low
52 Week's High
$3.86
52-Week Price Range
$9.15
$9.05
57.35%
Downside
1.10%
Upside

Evolus share price movements today

Previous Close: $9.06
Open: $9.08
Volume: 1.1M
Market Cap: $598.4M
Day's Low - High: $8.91 - $9.08
52 Week Low - High: $3.86 - $9.15

Evolus Historical Returns

1 Month Return: + 47.88 %
3 Month Return: + 37.12 %
1 Year Return: + 20.51 %
3 Year Return: -8.68 %
5 Year Return: -5.93 %

Evolus Stock Fundamentals & Key Indicators

Check Evolus market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$598.4M

EPS (TTM)

-0.042

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

-12.8M

Revenue (TTM)

316.5M

Profit Margin

-10.85%

Return On Equity TTM

-18729.61%

Evolus vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Evolus with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Evolus	BUY	$598.4M	-5.93%	NA	-10.85%	NA
United Therapeutics	BUY	$21.1B	132.56%	16.22	86.14%	NA
Viatris	HOLD	$19.1B	13.77%	-47.06	34.83%	2.83%
Haleon PLC Sponsored ADR	BUY	$43.9B	NA	20.65	14.55%	125.08999999999999%
Zoetis	BUY	$31.9B	-63.62%	12.55	70.87%	2.74%

See all

Stock Returns calculator for Evolus Stock including INR - Dollar returns

The Evolus stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Evolus investment value today

Current value as on today

₹1,29,103

Returns

₹29,103

(+29.1%)

Returns from Evolus Stock

₹20,506 (+20.51%)

Dollar Impact

₹8,597 (+8.6%)

Analyst Recommendation on Evolus Stock

Based on 5 analysts

BUY

80.00%

Buy

20.00%

Hold

0.00%

Sell

Based on 5 analysts, 80% of analysts recommend a 'BUY' rating for Evolus. Average target price of $15

Evolus Share Price Target

Get share price movements and forecasts by analysts on Evolus.

What analysts predicted

39.67%UPSIDE

Target Price

$15

Current Price

$9.05

Analyzed by

5 Analysts

Target

$15.00

Evolus target price $15, a slight upside of 39.67% compared to current price of $9.05. According to 5 analysts rating.

Indian Investors' Interest in Evolus Stock

Search interest for Evolus Stock has increased by 7% in the last 30 days, reflecting an upward trend in search activity.

Time period: August 5, 2026 to September 4, 2026

Change:7% versus previous 30 day period

Evolus Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Total Revenue	59	66	61	78	68	69	68	90	73	84
Gross Profit	40	47	42	50	46	45	45	59	47	57
Operating Income	-8	-7	-15	-2	-15	-10	-11	0	-6	-4
EBITDA	-6	-5	-13	0	-12	-7	-9	7	-3	-4
Interest Expense	4	4	4	4	4	7	4	3	3	4
Depreciation	1	1	1	1	1	2	2	2	2	2
Income Before Tax	-13	-11	-19	-6	-18	-17	-15	0	-10	-8
Income Tax Expense	0	0	0	0	0	0	0	0	0	0
Net Income	-13	-11	-19	-6	-18	-17	-15	0	-10	-8
Net Profit Margin	-22.09%	-16.96%	-31.38%	-8.60%	-27.57%	-24.70%	-22.82%	0.14%	-14.59%	-9.58%

Evolus Annual Profit & Loss

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	-	-	-	34	56	99	148	202	266	297
Gross Profit	0	0	-	26	38	56	89	140	182	192
Operating Income	-19	-11	-46	-98	-153	-44	-65	-49	-34	-37
EBITDA	-19	-11	-45	-92	-144	-39	-53	-41	-25	-22
Interest Expense	-	-	0	7	10	1	9	13	18	19
Depreciation	-	0	0	5	7	6	4	5	6	8
Income Before Tax	-19	-11	-46	-105	-162	-46	-74	-61	-49	-50
Income Tax Expense	0	-7	0	-15	0	0	0	0	0	0
Net Income	-20	-4	-46	-90	-163	-46	-74	-61	-50	-51
Net Profit Margin	0.00%	0.00%	0.00%	-257.79%	-288.31%	-46.96%	-50.07%	-30.52%	-18.94%	-17.38%

Evolus Quarterly Cash Flow

All numbers in Millions USD

	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Net Income	-11	-19	-6	-18	-17	-15	0	-10	-8
Operating Cash Flow	-6	-5	4	-15	-24	-14	12	-9	-3
Investing Cash Flow	-1	-1	-1	-1	-2	-2	-2	-1	0
Financing Cash Flow	4	-1	-1	-1	20	-1	0	7	0
Change in Cash	-3	-8	1	-19	-6	-18	10	-4	-4

Evolus Annual Cash Flow

All numbers in Millions USD

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-4	-46	-90	-163	-46	-74	-61	-50	-51
Operating Cash Flow	-13	-25	-93	-57	-33	-84	-34	-17	-42
Investing Cash Flow	0	0	-23	12	4	-2	-1	-4	-8
Financing Cash Flow	13	118	133	38	73	-4	44	47	17
Change in Cash	0	93	16	-7	43	-92	8	24	-33

Mutual Funds that own Evolus Stock

Check out the Mutual Funds with significant holdings in Evolus.

Funds	Holdings	Shares Held
VANGUARD INDEX FUNDS	3.646237%	2408356
TIAA-CREF Funds	0.936485%	618553
Fidelity Salem Street Trust	0.920184%	607786
Fidelity Concord Street Trust	0.818875%	540871
VANGUARD SCOTTSDALE FUNDS	0.467217%	308599

See all

Global Institutional Holdings in Evolus

Funds	Holdings
Vanguard	4.32%
iShares	4.07%
Joseph Edelman	3.72%
Xtrackers	1.88%
SPDR	1.06%

See all

Insights on Evolus

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 1 month, EOLS stock has moved up by 47.9%
POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 2 quarters, 73.13M → 84.08M (in $), with an average increase of 13.0% per quarter
POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 2 quarters, -10.67M → -8.05M (in $), with an average increase of 32.6% per quarter
NO EFFECT
Against Peers
In the last 1 year, Viatris Inc. Common Stock has given 64.0% return, outperforming this stock by 43.5%
NO EFFECT
Against Peers
In the last 3 years, United Therapeutics Corporation Common Stock has given 57.0% return, outperforming this stock by 65.7%

About Evolus

Evolus, Inc., a performance beauty company, delivers products in the cash-pay aesthetic market in the United States, Canada, Europe, and Australia. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults; and Evolysse, a collection of injectable hyaluronic acid gels, which includes various products, such as mid face, nasolabial folds, lips and eyes. The company was incorporated in 2012 and is headquartered in Newport Beach, California.

Organisation	Evolus
Headquarters	520 Newport Center Drive, Newport Beach, CA, United States, 92660
Industry	Drug Manufacturers - Specialty & Generic
CEO	Mr. David Moatazedi
E-voting on shares	Click here to vote

Key Management of Evolus

Name	Title
Ms. Jessica Novak	Senior Vice President of Human Resources
Mr. Jeffrey J. Plumer	Corporate Secretary
Mr. David Moatazedi	President, CEO & Director
Ms. Tatjana Mitchell	Chief Financial Officer
Dr. Rui Avelar C.CFP, Dip.SportMed, M.D.	Chief Medical Officer and Head of Research & Development
Mr. Nareg Sagherian	Head of Global Investor Relations & Corporate Communications
Mr. Kurt Knab	Senior Vice President of Sales

FAQs

What is Evolus share price today?

Evolus share price today is $9.05 as on September 4, 2026 at 8:45 am IST at the close of the market. Evolus share today touched a day high of $9.08 and a low of $8.91.

What is the 52 week high and 52 week low for Evolus share?

Evolus share touched a 52 week high of $9.15 on August 31, 2026 and a 52 week low of $3.86 on March 30, 2026. Evolus stock price today i.e. September 4, 2026 at 8:45 am IST is closed at $9.05,which is 1.09% down from its 52 week high and 134.46% up from its 52 week low.

What is Evolus's market capitalisation today?

Evolus market capitalisation is $0.00T as on September 4, 2026 at 8:45 am IST.

How to invest in Evolus Stock (EOLS) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Evolus on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Evolus Shares that will get you 0.1657 shares as per Evolus share price of $9.05 per share as on September 4, 2026 at 8:45 am IST.

What is the minimum amount required to buy Evolus Stock (EOLS) from India?

Indian investors can start investing in Evolus (EOLS) shares with as little as ₹94.485 or $1 (as of September 4, 2026 at 5:56 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹944.85 in Evolus stock (as per the Rupee-Dollar exchange rate as on September 4, 2026 at 5:56 pm IST). Based on Evolus share’s latest price of $9.05 as on September 4, 2026 at 8:45 am IST, you will get 1.1050 shares of Evolus. Learn more about fractional shares .

What are the returns that Evolus has given to Indian investors in the last 5 years?

Evolus stock has given -5.93% share price returns and 29.94% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?